CM
ABEO icon

Caption Management’s Abeona Therapeutics ABEO Stock Holding History

Caption Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-435,000
Closed -$2.3M – 1520
2025
Q3 		$2.3M Sell
435,000
-557,300
-56% -$3.53M 0.02% 794
2025
Q2 		$5.64M Buy
+992,300
New +$5.65M 0.06% 366
2018
Q3 		– Sell
-1,000
Closed -$400K – 495
2018
Q2 		$400K Buy
+1,000
New +$437K 0.03% 333

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caption Management's ABEO Position: Q2 2026 in Review

Caption Management sold out of Abeona Therapeutics (ABEO) in Q2 2026, closing a stake of 4,874 shares — an estimated $21.8K sold.

Caption Management first reported a position in ABEO in Q3 2019 and held it in 4 quarters. The position peaked at $301K in Q4 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Caption Management reported no remaining Abeona Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 4,874 Abeona Therapeutics shares in Q2 2026, an estimated $21.8K.
  • Caption Management first reported a position in Abeona Therapeutics in Q3 2019 and held it in 4 quarters.
  • Caption Management's Abeona Therapeutics position peaked at $301K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.